Skip to main content
Log in

Cerebrotendinous xanthomatosis: cranial CT and MRI studies in eight patients

  • Diagnostic Neuroradiology
  • Published:
Neuroradiology Aims and scope Submit manuscript

Summary

We report the findings on cranial computed tomography (CT) and magnetic resonance imaging (MRI) and their correlation with the clinical manifestations, disease severity and biochemical abnormalities in eight patients with cerebrotendinous xanthomatosis. CT revealed cerebral atrophy in seven cases, cerebellar atrophy in four and focal low density lesions in the cerebral white matter in two. T2-weighted MRI showed high signal lesions in the cerebral white matter, focal in four cases and diffuse in one, and in the globus pallidus in three patients, two of whom also had lesions in the cerebellar white matter. While severely affected patients showed variable CT and MRI abnormalities, our cases did not show the dramatic findings expected from the neurological manifestations. Diffuse lesions in the cerebral and cerebellar white matter have been emphasized in previous reports, but in our study the focal lesions in the cerebral white matter were also present; the globus pallidus was frequently involved.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Björkhem I, Skrede S (1989) Familial diseases with storage of sterols other than cholesterol: cerebrotendinous xanthomatosis and phytosterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn. McGraw-Hill, New York, pp 1283–1302

    Google Scholar 

  2. Iwamoto N, Tsukada N, Tsukagoshi H (1980) A case of cerebrotendinous xanthomatosis (in Japanese). Metab Dis 17: 1765–1772

    Google Scholar 

  3. Berginer VM, Berginer J, Salen G, Shefere S, Zimmerman RD (1981) Computed tomography in cerebrotendinous xanthomatosis. Neurology 31: 1463–1465

    Google Scholar 

  4. Canelas HM, Quintão ECR, Scaff M, Vasconcelos KS, Brotto MWI (1983) Cerebrotendinous xanthomatosis: clinical and laboratory study of 2 cases. Acta Neurol Scand 67: 305–311

    Google Scholar 

  5. Orimo S, Kobayashi T, furukawa T, Tsukagoshi H, Kano I (1984) Two cases of familial cerebrotendinous xanthomatosis. Intrahepatic enzyme assay and therapeutic trial with chenodeoxycholic acid (in Japanese). Clin Neurol 24: 38–44

    Google Scholar 

  6. Pop PHM, Joosten E, Spreeken A van, Gabreëls-Festen A, Jaspar H, Laak H ter, Vos A (1984) Neuroaxonal pathology of central and peripheral nervous systems in cerebrotendinous xanthomatosis (CTX). Acta Neuropathol (Berl) 64: 259–264

    Google Scholar 

  7. Hinman RC (1984) Cerebrotendinous xanthomatosis in Hawaii — a therapeutic failure. Hawaii Med J 43: 472–478

    Google Scholar 

  8. Berginer VM, Salen G, Shefer S (1984) Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. N Engl J Med 311: 1649–1652

    Google Scholar 

  9. Waterreus RJ, Koopman BJ, Wolthers BG, Oosterhuis HJGH (1987) Cerebrotendinous xanthomatosis (CTX): a clinical survey of the patient population in the Netherlands. Clin Neurol Neurosurg 89: 169–175

    Google Scholar 

  10. Higa H, Yonamine K, Yonamine T, Heiyanyama H, Gushiken H, (1987) Four cases of cerebrotendinous xanthomatosis (in Japanese). Okinawa Med J 24: 207–210

    Google Scholar 

  11. Berginer VM, Foster NL, Sadowsky M, Townsend III JA, Siegel GJ, Salen G (1988) Psychiatric disorders in patients with cerebrotendinous xanthomatosis. Am J Psychiatry 145: 354–357

    Google Scholar 

  12. Diedrich U, Ropte S (1989) Cerebrotendinöse Xanthomatose: Beschreibung zweier Fälle und Differentialdiagnose zur Encephalomyelitis disseminata. Nervenarzt 60: 444–447

    Google Scholar 

  13. Hwang SY, Lee KH, Ahn JI (1990) Cerebrotendinous xanthomatosis. J Dermatol 17: 115–119

    Google Scholar 

  14. Pedley TA, Emerson RG, Warner CL, Rowland LP, Salen G (1985) Treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid. Ann Neurol 18: 517–518

    Google Scholar 

  15. Swanson PD, Cromwell LD (1986) Magnetic resonance imaging in cerebrotendinous xanthomatosis. Neurology 36: 124–126

    Google Scholar 

  16. Burnstein M, Buckwalter KA, Martel W, McClatchey KD, Quint D (1987) Case report 427. Skeletal Radiol 16: 346–349

    Google Scholar 

  17. Fukuo Y, Hayama N, Hara K, Terashi A, Seta K (1989) Effect of LDL-apharesis on a case of cerebrotendinous xanthomatosis (in Japanese). Clin Neurol 29: 196–201

    Google Scholar 

  18. Amiel H, Gherardi R, Kanaan HY, Buisson J, Genthon R, Zinszner J, Giroux C, Delaporte P, Salama J (1989) Xanthomatose cérébro-tendineuse: à propos d'un cas comportant une étude en résonance magnétique de l'encéphale et une biopsie nerveuse. Ann Med Interne 140: 525–527

    Google Scholar 

  19. Fiorelli M, Di Piero V, Bastianello S, Bazzao L, Federico A (1990) Cerebrotendinous xanthomatosis: clinical and MRI study (a case report). J Neurol Neurosurg Psychiatry 53: 76–78

    Google Scholar 

  20. Bencze KS, Vande Polder DR, Prockop LD (1990) Magnetic resonance imaging of the brain and spinal cord in cerebrotendinous xanthomatosis. J Neurol Neurosurg Psychiatry 53: 166–167

    Google Scholar 

  21. Odaka H, Takizawa T, Mikami Y, Homma Y, Araki G (1990) Brain MRI findings in cerebrotendinous xanthomatosis (in Japanese). Neurol Med 33: 93–94

    Google Scholar 

  22. Shiga Y, Mochizuki H, Sahara M, Mochizuki R, Takase S (1990) A case of cerebrotendinous xanthomatosis. Therapeutic trial HMG CoA reductase inhibitor (in Japanese). Neurol Med 33: 235–237

    Google Scholar 

  23. Shibata N, Moroo I, Hayashi M (1990) Parkinsonism associated with cerebrotendinous xanthomatosis (in Japanese). Clin Neurol 30: 978–984

    Google Scholar 

  24. Kuriyama M, Fujiyama J, Yoshidome H, Takenaga S, Matsumuro K, Kasama T, Fukuda K, Kuramoto T, Hoshita T, Seyama Y, Okatsu Y, Osame M (1991) Cerebrotendinous xanthomatosis: clinical and biochemical evaluation of 8 patients with literature review. J Neurol Sci 102: 225–232

    Google Scholar 

  25. Kasama T, Byun DS, Seyama Y (1987) Quantitative analysis of sterols in serum by high-perfomance liquid chromatography. Application to the biochemical diagnosis of cerebrotendinous xanthomatosis. J Chromatogr 400: 241–245

    Google Scholar 

  26. Van Bogaert L, Scherer JH, Froelich A, Epstein E (1937) Une deuxiéme observation de cholestérinose tendineuse symmétrique avec symptomes cérébraux. Ann Med 42: 69–101

    Google Scholar 

  27. Schimschock JR, Alvord EC, Swanson PD (1968) Cerebrotendinous xanthomatosis: clinical and pathological studies. Arch Neurol 18: 688–698

    Google Scholar 

  28. Philippart M, Bogaert L van (1969) Cholestanolosis (cerebrotendinous xanthomatosis): a follow-up study on the original family. Arch Neurol 21: 603–610

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hokezu, Y., Kuriyama, M., Kubota, R. et al. Cerebrotendinous xanthomatosis: cranial CT and MRI studies in eight patients. Neuroradiology 34, 308–312 (1992). https://doi.org/10.1007/BF00588188

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00588188

Key words

Navigation